InvestorsHub Logo
Followers 1
Posts 337
Boards Moderated 0
Alias Born 11/08/2011

Re: Deep Pockets 11 post# 14164

Friday, 07/16/2021 7:33:45 AM

Friday, July 16, 2021 7:33:45 AM

Post# of 16554
"Please give us the names of companies that have walked away from nanologix"

AbbVie (NYSE:ABBV) $113.7 billion
Adaptive Biotechnologies (NASDAQ:ADPT) $3.4 billion
Alexion Pharmaceuticals (NASDAQ:ALXN) $21.7 billion
Alnylam Pharmaceuticals (NASDAQ:ALNY) $12.6 billion
Amgen (NASDAQ:AMGN) $122.9 billion
Bayer (OTC:BAYR.Y) $60.2 billion
Biogen (NASDAQ:BIIB) $54.1 billion
CSL Behring $89.8 billion
CytoDyn (NASDAQOTH:CYDY) $1.3 billion
Emergent BioSolutions (NYSE:EBS) $3.1 billion
Gilead Sciences (NASDAQ:GILD) $96.6 billion
Grifols (NASDAQ:GRFS) $19.5 billion
Incyte (NASDAQ:INCY) $18 billion
Eli Lilly (NYSE:LLY) $135.8 billion
Mesoblast (NASDAQ:MESO) $6.1 billion
Novartis (NYSE:NVS) $193.1 billion
Regeneron Pharmaceuticals (NASDAQ:REGN) $55.5 billion
Roche Holding (OTC:RHHBY) $286.7 billion
Sanofi $112.9 billion
Takeda Pharmaceutical (NYSE:TAK) $47.6 billion
Vanda Pharmaceuticals (NASDAQ:VNDA) $568.7 million
Vir Biotechnology (NASDAQ:VIR) $3.9 billion
Abbott Labs (NYSE:ABT) $142 billion
Bayer $60.2 billion
Becton Dickinson (NYSE:BDX) $63.2 billion
bioMerieux (OTC:BMXMF) $13.2 billion
Co-Diagnostics (NASDAQ:CODX) $273 million
Danaher (NYSE:DHR) $98.5 billion
Eli Lilly $135.8 billion
Grifols $19.5 billion
LabCorp (NYSE:LH) $11.9 billion
OPKO Health (NASDAQ:OPK) $817.2 million
Quest Diagnostics (NYSE:DGX) $10.4 billion
Roche Holdings $286.7 billion
Thermo Fisher Scientific (NYSE:TMO) $117.7 billion
Arcturus Therapeutics (NASDAQ:ARCT) $249.1 million
BioNTech (NASDAQ:BNTX) $12.2 billion
CSL Behring (OTC:CSLL.Y) $89.8 billion
Dynavax (NASDAQ:DVAX) $293.9 million
GlaxoSmithKline (NYSE:GSK) $93.7 billion
Inovio Pharmaceuticals (NASDAQ:INO) $1.2 billion
Johnson & Johnson (NYSE:JNJ) $357.9 billion
Moderna (NASDAQ:MRNA) $11.4 billion
Novavax (NASDAQ:NVAX) $821.8 million
Pfizer (NYSE:PFE) $190.2 billion
Sanofi (NASDAQ:SNY) $112.9 billion
TranslateBio (NASDAQ:TBIO) $614.1 million



Do you think these companies don't keep an eye on potential competition that has the Holy Cow? What you need is just one that hasn't walked away.